Table: AFC-HD Ams Life Science -Q1 group results

AFC-HD AMS Life Science

12/01/2024 06:00

Jan 12 (Reuters)- 
             AFC-HD Ams Life Science Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Nov 30, 2023        Nov 30, 2022     Aug 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               6.79                5.69             28.46    
                   (+19.3 pct)         (+4.1 pct)       (+11.2 pct) 
  Operating          478 mln             221 mln            1.80    
                  (+115.9 pct)         (+32.6 pct)      (+10.1 pct) 
  Recurring          489 mln             236 mln            1.79    
                  (+106.9 pct)         (-25.3 pct)      (+8.1 pct)  
  Net                318 mln             160 mln            1.12    
                   (+98.3 pct)         (+2.8 pct)       (+1.9 pct)  
  EPS               22.80 yen           11.44 yen        80.42 yen  
  EPS Diluted       22.79 yen           11.43 yen                   
  Ann Div                               27.50 yen        30.00 yen  
  -Q2 div                               12.50 yen        15.00 yen  
  -Q4 div                               15.00 yen        15.00 yen  
  
  NOTE - AFC-HD Ams Life Science Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T